Atlas Trials

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

Clinical trial NCT00210080 · COMPLETED

Trial details

NCT number
NCT00210080
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2001-04-01
Primary completion
2003-12-01
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.